Nuix Ltd
OTC:NXLLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nuix Ltd
OTC:NXLLF
|
AU |
|
CleanSpark Inc
NASDAQ:CLSK
|
US |
|
Maxell Ltd
TSE:6810
|
JP |
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
|
Mirae Asset Securities Co Ltd
KRX:006800
|
KR |
|
R
|
Region Re Ltd
ASX:RGN
|
AU |
|
R
|
R&G PharmaStudies Co Ltd
SZSE:301333
|
CN |
|
Conmed Corp
NYSE:CNMD
|
US |
Wall St Price Targets
NXLLF Price Targets Summary
Nuix Ltd
According to Wall Street analysts, the average 1-year price target for NXLLF is 1.82 USD with a low forecast of 1.6 USD and a high forecast of 2.35 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NXLLF's stock price target?
Price Target
1.82
USD
According to Wall Street analysts, the average 1-year price target for NXLLF is 1.82 USD with a low forecast of 1.6 USD and a high forecast of 2.35 USD.
What is the Revenue forecast for Nuix Ltd?
Projected CAGR
11%
Over the last 7 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 4 years is 11%.
What is the Gross Profit forecast for Nuix Ltd?
Projected CAGR
11%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 4 years is 11%.
What is the Operating Income forecast for Nuix Ltd?
Projected CAGR
111%
Over the last 7 years, the compound annual growth rate for Operating Income has been -9%. The projected CAGR for the next 3 years is 111%.
